AllPennyStocks.com IBRX Stock Eyes Worst Week Since July: New Patent Eyes Broader Anktiva Use Ahead Of Lung Cancer Conference
This section contains press releases and other materials from third parties (including paid content). AllPennyStocks.com has not reviewed this content. Please see our disclaimer.

IBRX Stock Eyes Worst Week Since July: New Patent Eyes Broader Anktiva Use Ahead Of Lung Cancer Conference

A new patent application covers using Anktiva to restore immune cells depleted by cancer treatments.

Other Penny Stock Movers

SaaS Provider Surges 22% on Profitability Targets
BC Copper-Gold Explorer Surges 40% on Maiden Drill Visuals
Why Mining Giants Keep Buying the Ground Next Door
Most Popular
{{ index + 1 }}
AllPennyStocks.com Favorites


Back to Top